RVL Pharmaceuticals (RVLP)

Data from SEC filings
Employee count
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

At the Extraordinary General Meeting, the Company’s shareholders approved the proposal to change the Company’s name from Osmotica Pharmaceuticals plc to RVL Pharmaceuticals plc, based on the following votes: